Psych News Alert | FDA

FDA Announces Elimination of Clozapine REMS

Feb 25, 2025 12:00:00 AM

Reviewing the FDA’s Major Psychiatry Approvals in 2024

Dec 27, 2024 12:00:00 AM

FDA Panel Votes 14-1 Against Clozapine REMS

Nov 20, 2024 12:00:00 AM

FDA Sends Back PharmaTher’s Ketamine Application

Oct 24, 2024 12:00:00 AM

Lykos Therapeutics’ Psychedelic MDMA Not Approved by FDA

Aug 12, 2024 12:00:00 AM

Meta-Analysis Reveals Disappointing Efficacy for Esketamine in Depression, Suicidality

Jun 24, 2024 11:16:15 AM